DR AZIDA JUANA BINTI WAN AB KADIR
Name
DR AZIDA JUANA BINTI WAN AB KADIR
Nationality
Malaysia
Gender
Female
Age
52
Role
Director
Working Experience
Dr. Azida Juana Binti Wan Ab Kadir was appointed as a lecturer in the Department of Ophthalmology at the Faculty of Medicine, Universiti of Malaya since 2001. She receives subspecialty fellowship training in
Cornea, Anterior Segment and Refractive Surgery at the Eye Institute, Tan Tock Seng Hospital, Singapore. Additionally, she is a member of the National Specialist Registry (NSR). Dr. Azida received an award from the Universiti Malaya Medical Centre for her excellent services during the COVID-19 outbreak.
Cornea, Anterior Segment and Refractive Surgery at the Eye Institute, Tan Tock Seng Hospital, Singapore. Additionally, she is a member of the National Specialist Registry (NSR). Dr. Azida received an award from the Universiti Malaya Medical Centre for her excellent services during the COVID-19 outbreak.
| Company | Name |
|---|
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
Market Buzz
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-19
2024-12-16
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-12-19 16:40:00
ADX
10 Mins
SELL
2024-12-19 15:30:00
EMA 5
5 Mins
SELL
2024-12-19 15:30:00
EMA 5
10 Mins
SELL
2024-12-19 15:00:00
TURTLE SYSTEM 20
5 Mins
SELL
2024-12-19 14:50:00
EMA 5
10 Mins
BUY
Apps
Top Articles
1
2
Stock Market Enthusiast
3
4
7
TA Sector Research
8
Good Articles to Share
Kamala Harris makes this clear during speech to supporters #shorts
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
